Volume 24, Issue 3 (1994) Symposium on the U.S. Pharmaceutical Industry in the 1900s: Facing Health Care Reform, Regulation, and Judicial Controls
Editorial Board
Table of Contents
Articles
Health Reform and Pharmaceutical Innovation
Henry Grabowski
Some Effects of the Clinton Health Care Reform Proposals on Regulated Aspects of the Pharmaceutical Industry
Richard M. Cooper
Impact on the Pharmaceutical Industry of Changes in the American Health Care System: A Physician's Perspective
Michael A. Weber
FDA Efforts to Control the Flow of Information at Pharmaceutical Industry-Sponsored Medical Education Programs: A Regulatory Overdose
Charles J. Walsh and Alissa Pyrich
Economic Analysis and the Regulation of Pharmaceutical Advertising
J. Howard Beales III
A Statistical Profile of Pharmaceutical Industry Liability, 1976-1989
W. Kip Viscusi, Michael J. Moore, and James Albright
Deterring Inefficient Pharmaceutical Litigation: An Economic Rationale for the FDA Regulatory Compliance Defense
W. Kip Viscusi, Steven R. Rowland, Howard L. Dorfman, and Charles J. Walsh
Comment
Innocents Imprisoned: The Deficiencies of the New Jersey Standard Governing the Involuntary Commitment of Children
Louis A. Chiafullo